Human Genome Sciences, Inc.

Form 483 issued December 11, 2023 · Rockville, Maryland

Inspection
Dec 1 – Dec 11, 2023
Observations
6
Pages
5
FEI number
3003782237

In short: On December 11, 2023, FDA issued a Form 483 with 6 observations to Human Genome Sciences, Inc. in Rockville, Maryland (FEI 3003782237) after an inspection that ran Dec 1 – Dec 11, 2023. The investigators were Brian M. Janelsins, Teegan A. Dellibovi-Ragheb and Wendy G. Tan. Most observations concern production and quality system; the most-cited regulation is 21 CFR 211.113 (control of microbiological contamination).

At a glance

Production and quality system account for 5 of 6 observations.

Production3
Quality system2
Materials1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Microbial control procedures for drug substance…

  2. 02

    Root cause analysis and CAPA implementation as…

  3. 03

    Written procedures to ensure maintenance of data integrity and product quality are inadequate…

  4. 04

    Training procedures are inadequate…

2 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Human Genome Sciences, Inc.?

FDA listed 6 observations on this Form 483, mostly about production, quality system and materials. The most-cited regulation is 21 CFR 211.113 (control of microbiological contamination). The opening words of each observation are shown on this page.

Who inspected Human Genome Sciences, Inc.?

Brian M. Janelsins, Teegan A. Dellibovi-Ragheb and Wendy G. Tan are named on this Form 483, for the inspection of Dec 1 – Dec 11, 2023. Each investigator has a profile showing what they cite most.

When was Human Genome Sciences, Inc. inspected by FDA?

The inspection ran Dec 1 – Dec 11, 2023, and the Form 483 is dated December 11, 2023.

How do I get the full Form 483 for Human Genome Sciences, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free